These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7912507)
1. Specific lymphocytotoxic destruction of autologous epithelial cell targets in recurrent aphthous stomatitis. Savage NW; Seymour GJ Aust Dent J; 1994 Apr; 39(2):98-104. PubMed ID: 7912507 [TBL] [Abstract][Full Text] [Related]
2. Expression of class I and class II major histocompatibility complex antigens on epithelial cells in recurrent aphthous stomatitis. Savage NW; Seymour GJ; Kruger BJ J Oral Pathol; 1986 Apr; 15(4):191-5. PubMed ID: 3088233 [TBL] [Abstract][Full Text] [Related]
3. The role of autologous tumor cells in preventing lymphokine-activated killer cell induction in vitro. Slovin SF; Maguire HC; Mastrangelo MJ Cancer; 1990 Dec; 66(12):2541-6. PubMed ID: 2123415 [TBL] [Abstract][Full Text] [Related]
4. Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients. Fujimiya Y; Suzuki Y; Katakura R; Ohno T J Hematother; 1999 Feb; 8(1):29-37. PubMed ID: 10192299 [TBL] [Abstract][Full Text] [Related]
5. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis. Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707 [TBL] [Abstract][Full Text] [Related]
6. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
8. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients. de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753 [TBL] [Abstract][Full Text] [Related]
9. Characterisation of the effector cells responsible for the in vitro cytotoxicity of blood leucocytes from aphthous ulcer patients for oral epithelial cells. Thomas DW; Bagg J; Walker DM Gut; 1990 Mar; 31(3):294-9. PubMed ID: 2323592 [TBL] [Abstract][Full Text] [Related]
10. Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome. Rogers RS; Sams WM; Shorter RG Arch Dermatol; 1974 Mar; 109(3):361-3. PubMed ID: 4814937 [No Abstract] [Full Text] [Related]
11. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status. Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694 [TBL] [Abstract][Full Text] [Related]
12. Lytic effect of cytotoxic lymphocytes on oral epithelial cells in Behçet's disease. Reimer G; Steinkohl S; Djawari D; Hornstein OP Br J Dermatol; 1982 Nov; 107(5):529-36. PubMed ID: 6982060 [TBL] [Abstract][Full Text] [Related]
13. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Freysdottir J; Lau S; Fortune F Clin Exp Immunol; 1999 Dec; 118(3):451-7. PubMed ID: 10594567 [TBL] [Abstract][Full Text] [Related]
14. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture. Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277 [TBL] [Abstract][Full Text] [Related]
16. The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2. Hancock GE; Cohn ZA; Kaplan G J Exp Med; 1989 Mar; 169(3):909-19. PubMed ID: 2522499 [TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype. Patel SS; Thiele DL; Lipsky PE J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232 [TBL] [Abstract][Full Text] [Related]
18. The effect of lymphocytes from sufferers from recurrent aphthous ulceration upon colon cells in tissue culture. Dolby AE Gut; 1972 May; 13(5):387-9. PubMed ID: 5036095 [TBL] [Abstract][Full Text] [Related]
19. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer]. You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341 [TBL] [Abstract][Full Text] [Related]
20. Characterization of human cytotoxic lymphocytes directed against cells infected with typhus group rickettsiae: evidence for lymphokine activation of effectors. Carl M; Dasch GA J Immunol; 1986 Apr; 136(7):2654-61. PubMed ID: 3081648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]